Business
Haemonetics 1st Quarter Fiscal Year 2026 Earnings Release Available on Investor Relations Website
Haemonetics Corporation (NYSE: HAE) announced that financial results for its first quarter fiscal year 2026, which ended June 28, 2025, are available on its Investor Relations website.
About this update from Haemonetics Corporation
Financial release accessible online BOSTON , Aug. 7, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its first quarter fiscal year 2026, which ended June 28, 2025 , are available on its Investor Relations website. The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. ET on August 7, 2025 . The conference call and webcast can be accessed with the following information: In addition, the Company has posted to its Investor Relations website the earnings release that will be referenced on its conference call and webcast, a link to which is available below. Direct link to 1Q FY26 Earnings Release: https://haemonetics.gcs-web.com/static-files/078498e0-b75c-4cd4-94fb-93730b3b1c70 A replay of the conference call and webcast will be available for one year beginning on August 7, 2025 , at 11:00 a.m. ET using the conference call webcast link provided in this press release. ABOUT HAEMONETICS Haemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our innovative solutions addressing critical medical needs include a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers; and products to enable blood centers to collect in-demand blood components. To learn more about Haemonetics, visit www.haemonetics.com . View original content to download multimedia: https://www.prnewswire.com/news-releases/haemonetics-1st-quarter-fiscal-year-2026-earnings-release-available-on-investor-relations-website-302523396.html SOURCE Haemonetics Corporation
View stock analysis, news, and events for Haemonetics Corporation